Join to access to all OVN content. Join for Free
How to Start Presenting Like a Pro
Master Presenter Medical Science Liaisons Presentation Skills Virtual Presence Key Opinion Leaders Storytelling Techniques AI Assessment Tools Interview Skills

How to Start Presenting Like a Pro


Share This Article


Summary

In this episode, Tom Caravela is joined by Sarah Snyder and Patrina Pellett to share expert advice on how to become a master presenter. They explore and discuss the many ways Medical Science Liaisons can improve their presentation skills through proven training methods and practices. The discussion highlights the evolution of MSL presentations as well as interview presentations emphasizing key components like virtual presence and properly engaging Key Opinion Leaders (KOLs). They also cover improving storytelling, energy, and interview skills, while discussing new AI assessment tools that is bringing MSLs to an entirely new level.

Key Points

  • Listening to and critiquing your own past performances is crucial for improving presentation skills.
  • Practicing with AI tools can provide immediate, data-driven feedback that helps refine presentation techniques.
  • Customizing presentation training to address individual and real-life scenarios can significantly enhance an MSL's effectiveness and confidence.

Click for Source
Master Presenter, Medical Science Liaisons, Presentation Skills, Virtual Presence, Key Opinion Leaders, Storytelling Techniques, AI Assessment Tools, Interview Skills

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Presentation Nails and Fails: 7 Tips to Ace Your Next MSL Presentation
Partner Avatar Bridget Rasmusson

Presentation Nails and Fails: 7 Tips to Ace Your Next MSL Presentation

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
The Strategic vs the Scientific MSL
Partner Avatar MSL Talk: Tom Caravela, Joy Morrell

The Strategic vs the Scientific MSL

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Explore OVN